Global Medical REIT Inc. (NYSE:XRN – Get Free Report) COO Danica Holley purchased 1,490 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average cost of $33.99 per share, for a total transaction of $50,645.10. Following the purchase, the chief operating officer directly owned 1,590 shares in the company, valued at $54,044.10. This trade represents a 1,490.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Global Medical REIT Stock Up 1.7%
NYSE:XRN traded up $0.57 on Tuesday, reaching $34.11. The stock had a trading volume of 422,301 shares, compared to its average volume of 119,647. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.62. The company has a 50-day moving average of $35.08 and a 200 day moving average of $34.42. The stock has a market cap of $451.21 million, a P/E ratio of -30.73 and a beta of 1.11. Global Medical REIT Inc. has a 12-month low of $29.05 and a 12-month high of $39.93.
Global Medical REIT Announces Dividend
The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 18th. Shareholders of record on Thursday, August 20th will be paid a dividend of $0.16 per share. This represents a c) dividend on an annualized basis and a yield of 5.6%. The ex-dividend date is Thursday, August 20th. Global Medical REIT’s dividend payout ratio (DPR) is -270.27%.
Institutional Investors Weigh In On Global Medical REIT
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Weiss Ratings lowered Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday. Compass Point reaffirmed a “neutral” rating and set a $38.00 price target (down from $50.00) on shares of Global Medical REIT in a research report on Thursday, May 7th. Finally, Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.67.
View Our Latest Analysis on Global Medical REIT
Global Medical REIT Company Profile
Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.
Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.
Read More
- Five stocks we like better than Global Medical REIT
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
